MedPath

VIATRIS PRIVATE LIMITED

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

50

HSA:50

Drug Approvals

BRILLIOR CAPSULE 75mg

Approval Date
Jan 16, 2014
HSA

BRILLIOR CAPSULE 150mg

Approval Date
Jan 16, 2014
HSA

BRILLIOR CAPSULE 25mg

Approval Date
Jan 16, 2014
HSA

CELEBREX CAPSULE 400MG

Approval Date
May 21, 2009
HSA

Eturion Tablet 40mg

Approval Date
Jun 22, 2007
HSA

Eturion Tablet 10mg

Approval Date
Jun 22, 2007
HSA

Eturion Tablet 80mg

Approval Date
Jun 22, 2007
HSA

Eturion Tablet 20mg

Approval Date
Jun 22, 2007
HSA

Revatio Film-Coated Tablets 20mg

Approval Date
Mar 30, 2007
HSA

Dilantin 125® (Phenytoin Oral Suspension, USP) 125mg/5ml

Approval Date
Jun 6, 2005
HSA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.